Actively Recruiting
Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery
Led by Istituto Clinico Humanitas · Updated on 2024-06-26
350
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the postoperative outcomes of low rectal cancer patients who underwent surgery with Natural Orifice Specimen Extraction (NOSE) versus traditional Pfannenstiel extraction.
CONDITIONS
Official Title
Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing low anterior resection with Total Mesorectal Excision (TME) for low rectal cancer between January 2017 and January 2023
- Patients with rectal cancer classified as "low" according to the English National Low Rectal Cancer Development Programme (LOREC)
You will not qualify if you...
- Patients undergoing non-restorative procedures
- Patients undergoing immediate or delayed handsewn coloanal anastomosis
- Patients undergoing planned open surgery or unplanned conversion from minimally invasive to open surgery
- Patients with a concomitant diagnosis of Inflammatory Bowel Disease (IBD)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Humanitas Research Hospital
Rozzano, MI, Italy, 20089
Actively Recruiting
Research Team
A
Annalisa Maroli, PhD
CONTACT
S
Stefano De Zanet, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here